chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Body temperature increased, Chest pain, Dizziness, Feeling hot, Insomnia
Clinical narrative: ON 08/15, ABOUT 6 HOURS AFTER VACCINE HE HAD A TEMPERATURE OF 102 WITHOUT HIS ARMS HURTING.  MOTRIN WAS GIVEN FOR HIS TEMPERATURE AND IT WENT DOWN.  HE ATE AND RAN AROUND AND PLAYED.  MOM REPORTS HE DIDN'T SLEEP UNTIL 2:00 ON 08/16 AND FELT HOT DIZZY, HIS NECK HURT AND COMPLAINED OF HIS CHEST HURTING WITH DEEP BREATHS AND WAS BREATHING FAST.  TEMP 104.  MOTRIN GIVEN AND HE FEELS BETTER.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Neck pain, Painful respiration, Respiratory rate increased
Clinical narrative: ON 08/15, ABOUT 6 HOURS AFTER VACCINE HE HAD A TEMPERATURE OF 102 WITHOUT HIS ARMS HURTING.  MOTRIN WAS GIVEN FOR HIS TEMPERATURE AND IT WENT DOWN.  HE ATE AND RAN AROUND AND PLAYED.  MOM REPORTS HE DIDN'T SLEEP UNTIL 2:00 ON 08/16 AND FELT HOT DIZZY, HIS NECK HURT AND COMPLAINED OF HIS CHEST HURTING WITH DEEP BREATHS AND WAS BREATHING FAST.  TEMP 104.  MOTRIN GIVEN AND HE FEELS BETTER.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Abdominal pain upper, Eye pruritus, Pruritus, Rash generalised, Vomiting
Clinical narrative: Tummy ache followed by vomiting followed by rash all over body. Itchy eyes and ears.
Age: 62.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Body temperature decreased, Chills, Dizziness, Hyperhidrosis, Hypotension
Clinical narrative: By mid afternoon my arm had swollen and was hot. By morning 9/7, it was 3 x its normal size, hot and very sore from shoulder to elbow and I awoke with chills, fever, sweating, nausea, blurred vision and feeling of faintness. When I arrived at the ER my blood pressure was abnormally low and my body temperature was < 96 degrees
Age: 62.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Nausea, Oedema peripheral, Pain in extremity, Pyrexia, Skin warm
Clinical narrative: By mid afternoon my arm had swollen and was hot. By morning 9/7, it was 3 x its normal size, hot and very sore from shoulder to elbow and I awoke with chills, fever, sweating, nausea, blurred vision and feeling of faintness. When I arrived at the ER my blood pressure was abnormally low and my body temperature was < 96 degrees
Age: 62.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Vision blurred
Clinical narrative: By mid afternoon my arm had swollen and was hot. By morning 9/7, it was 3 x its normal size, hot and very sore from shoulder to elbow and I awoke with chills, fever, sweating, nausea, blurred vision and feeling of faintness. When I arrived at the ER my blood pressure was abnormally low and my body temperature was < 96 degrees
Age: 26.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Headache, Pallor
Clinical narrative: Dizziness, Headache, feeling faint, pale skin
Age: 26.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Headache, Hyperhidrosis, Immunisation reaction, Malaise
Clinical narrative: Dizziness, Headache, feeling faint, pale skin
Age: 26.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Pallor, Rash, Rash pruritic, Skin burning sensation, Tremor
Clinical narrative: Dizziness, Headache, feeling faint, pale skin
Age: 91.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Influenza like illness, Malaise, Pyrexia
Clinical narrative: Flu like symptoms - Chills, low-grade fever, malaise
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Influenza like illness, Malaise, Pyrexia
Clinical narrative: Flu like symptoms- low grade fever, chills malaise
Age: 0.64
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, PNC13
Symptoms: Urticaria
Clinical narrative: pt developed hives
Age: 1.1
Sex: F
Vaccine: HEPA, HIBV, MMR, PPV, VARCEL
Symptoms: Rash generalised, Rubella
Clinical narrative: Symptoms of yeast rash seemed to have spread all over, not only diaper area, but face also. Took her to the ER. They said she was allergic to the Nyzoral cream. Gave Zyrtec and Nystatin. Two days later on Monday the 15th of August, the rash had exploded all over her body. Took her back to the ER and they said it was a reaction to the MMR vaccine. No fever, or other cold like symptoms, just the rash. Doctor said it was classic Rubella markings.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Back pain, Neck pain, Paraesthesia
Clinical narrative: c/o neck & back pain, tingling throat
Age: 21.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Blood culture negative, Full blood count normal, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: PNEUMOVAX vaccine adm (R) deltoid on 8/31/11, later the same day pt developed swelling, tenderness & redness at site and surrounding area. Pt was examined in office on 9/1/11, (R) upper arm noted to be reddened, warm to touch & tender no fever no drng at injection site, Rx for KEFLEX given. On 9/2/11 pt c/o increase redness & increase pain & was advised to go ER ---> Pt admitted.
Age: 21.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Injection site warmth
Clinical narrative: PNEUMOVAX vaccine adm (R) deltoid on 8/31/11, later the same day pt developed swelling, tenderness & redness at site and surrounding area. Pt was examined in office on 9/1/11, (R) upper arm noted to be reddened, warm to touch & tender no fever no drng at injection site, Rx for KEFLEX given. On 9/2/11 pt c/o increase redness & increase pain & was advised to go ER ---> Pt admitted.
Age: 3.0
Sex: F
Vaccine: DTAP, DTAPIPVHIB, HEP, HEPA, IPV, MMR, PNC, VARCEL
Symptoms: Unevaluable event
Clinical narrative: Was to get single doses of DTAP, HIB, IPV, MMR, Hep B, VAX, PNU & Hep A. Actually received DTap, IPV, MMR, Hep B, VAX, PNU, Hep A & PENTACEL. Essentially rc'd 2 doses of DTaP & IPV. Family notified. No problem reported.
Age: 66.0
Sex: M
Vaccine: PPV, TDAP
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Pt states received Tetanus shot on (L) arm 8/31. States area swelled up to size of baseball, red & hot to the touch. Pt states he had a 25mg of BENADRYL and rubbed the area with alcohol. Pt called the office on 9-6-11 and was advised to come in for evaluation of area.
Age: 6.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Chest pain, Crying, Urticaria, Wheezing
Clinical narrative: Child received 4 imm at his 6 year well check. NKA. Child cried after imm. After 10 minutes child came back into office c/o chest pain. Child was wheezing, pulse ox 96 HR 88 no color changes. XOPENEX and BENADRYL given.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Rash vesicular
Clinical narrative: Onset of rash 09/6/11 typical of varicella.
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Vaccine given 11AM and 1 - 9/9/11 at clinic no complaints. At 1340 mother called, patient reporting tingling & numbness of left arm. Vaccines given in Rt arm. Symptoms started about noon have not gone away have not gotten worse.
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Haematoma
Clinical narrative: Hematoma (left arm).
Age: 5.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site papule, Injection site rash, Papule, Rash
Clinical narrative: Patient developed rash, 2-3 mm papules on face, (B) arms, trunk & back w/in minutes of receiving influenza vaccine. BENADRYL 25mg PO x 1 given. Rash then resolved. No respiratory distress, no n/v, no swelling or edema.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Lymphadenopathy
Clinical narrative: Rash (at injection site). Swollen glands near injection site.
Age: 23.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus
Clinical narrative: redness, itching at the site, about 6cm induration
Age: 1.43
Sex: F
Vaccine: DTAPIPVHIB, HEP, MMR, PNC13, VARCEL
Symptoms: Measles antibody, Pruritus generalised, Rash generalised, Rash pruritic
Clinical narrative: Child's entire body was covered in an itchy rash
Age: 27.0
Sex: F
Vaccine: MNQ
Symptoms: Back pain
Clinical narrative: Back pain
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus generalised, Rash
Clinical narrative: Patient developed a rash on the arm opposite the injection and generalized itching. EMS was called and patient was given an EpiPen injection at 2:05 PM.
Age: 23.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth, Local reaction
Clinical narrative: Localized injection site reaction - red, tender patch 3in in diameter directly above injection site.  Patient described it as itchy and warm to the touch.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Induration, Local swelling, Skin warm, Tenderness
Clinical narrative: localized warm, tenderness, swelling, and firmness
Age: 4.0
Sex: F
Vaccine: DTAPHEPBIP, PNC13
Symptoms: Injection site cellulitis, Local reaction
Clinical narrative: Large local reaction to left deltoid after vaccination (may be due to DTaP), diagnosed with cellulitis at outside emergency room
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling
Clinical narrative: According to the patient's mother, it's a large round raised circle at the injection site. The patient went to Urgent Care and was give an antibiotic shot and an oral antibiotic medication.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: Conjunctivitis, Myalgia, Oropharyngeal pain
Clinical narrative: beefy red exudative conjunctivitis, sore throat, myalgias
Age: 49.0
Sex: M
Vaccine: PPV
Symptoms: Body temperature increased, Hypoaesthesia, Oedema peripheral, Pain, Paraesthesia
Clinical narrative: 101.5 degrees F temperature, severe arm swelling, body aches, numbness & tingling in hands & feet.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Vomiting
Clinical narrative: Pt. had extreme nausea & vomiting.
Age: 7.0
Sex: M
Vaccine: HEPA
Symptoms: Asthenia, Gait disturbance, Guillain-Barre syndrome, Laboratory test, Lumbar puncture
Clinical narrative: Hepatitis A vaccine #2 given 7/2/11. Pt was well until febrile illness 8/19/11. Developed weakness, leg pain, difficulty walking on or around 8/28. Presented 8/29/11 with weakness to ED - admitted and treated for presumptive GUILLAIN BARRE Syndrome.
Age: 7.0
Sex: M
Vaccine: HEPA
Symptoms: Nuclear magnetic resonance imaging, Pain in extremity, Pyrexia
Clinical narrative: Hepatitis A vaccine #2 given 7/2/11. Pt was well until febrile illness 8/19/11. Developed weakness, leg pain, difficulty walking on or around 8/28. Presented 8/29/11 with weakness to ED - admitted and treated for presumptive GUILLAIN BARRE Syndrome.
Age: 39.0
Sex: U
Vaccine: PPV
Symptoms: Chills, Local reaction, Pain, Pyrexia
Clinical narrative: Local reaction at injection site, fever, chills, pain 10/10.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMR, PNC, VARCEL
Symptoms: Apnoea, Cyanosis, Laboratory test, Lethargy, Pallor
Clinical narrative: Syncope, cyanosis, apnea, pallor (5 min) after vaccine. Lethargy. Given oxygen and transported to hospital.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMR, PNC, VARCEL
Symptoms: Syncope
Clinical narrative: Syncope, cyanosis, apnea, pallor (5 min) after vaccine. Lethargy. Given oxygen and transported to hospital.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Hyperhidrosis, Musculoskeletal stiffness, Opisthotonus, Pallor, Posture abnormal
Clinical narrative: Gave HPV in (R) arm, sat needle down put Bandaid on, her head went down, no response, layed her down, her body stiffened & arched back then was not breathing for 15 sec. Started to talk when Dr. was examining her. She urinated, pale, sweaty. Came around about 3min. was able to sit up, talk, wait 20min. Recheck BP, P & was alert oriented able to walk out door.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Respiratory arrest, Unresponsive to stimuli, Urinary incontinence
Clinical narrative: Gave HPV in (R) arm, sat needle down put Bandaid on, her head went down, no response, layed her down, her body stiffened & arched back then was not breathing for 15 sec. Started to talk when Dr. was examining her. She urinated, pale, sweaty. Came around about 3min. was able to sit up, talk, wait 20min. Recheck BP, P & was alert oriented able to walk out door.
Age: 15.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site cellulitis
Clinical narrative: Cellulitis at injection site.
Age: 65.0
Sex: F
Vaccine: FLU3, PPV, TDAP
Symptoms: Erythema, Pyrexia
Clinical narrative: Received 3 vaccinations on 9/8/11. Flu vaccination in Rt arm. Received PNEUMOVAX and TDAP vaccinations left arm - presented with fever 101.2, erythematous area measuring 22cm x 17cm.
Age: 73.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Asthenia, Injection site pain, Malaise, Nausea
Clinical narrative: General malaise, weak. Pain at injection (PNEUMOVAX) site after 2 days. Sick to stomach.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site reaction, Rash erythematous, Skin warm
Clinical narrative: Pt had a huge red bump on left arm where KINRIX was given. Hot when felt.
Age: 1.01
Sex: M
Vaccine: FLU3, MMR, PNC, VARCEL
Symptoms: Erythema, Injection site erythema, Injection site induration, Injection site mass, Injection site warmth
Clinical narrative: On 9/5/11 mother not red spot with lump on (R) upper posterior thigh (VARIVAX vaccine site) vaccine administered on 8/26/11 at 4 pm. Pt seen in office on 9/7/11 & doc describes 1-5cm red area on (R) upper posterior thigh, with firm lump underlying red area measuring 1cm. No pustule or pimple. Second red erythematous papule on (L) posterior chest, mid area. Antibx given - KEFLEX though not likely infected.
Age: 1.01
Sex: M
Vaccine: FLU3, MMR, PNC, VARCEL
Symptoms: Papule
Clinical narrative: On 9/5/11 mother not red spot with lump on (R) upper posterior thigh (VARIVAX vaccine site) vaccine administered on 8/26/11 at 4 pm. Pt seen in office on 9/7/11 & doc describes 1-5cm red area on (R) upper posterior thigh, with firm lump underlying red area measuring 1cm. No pustule or pimple. Second red erythematous papule on (L) posterior chest, mid area. Antibx given - KEFLEX though not likely infected.
Age: 45.0
Sex: F
Vaccine: HEPA
Symptoms: Hypoaesthesia, Injection site pain
Clinical narrative: Immediate severe pain at time of administering of vaccine (L) arm. Numbness to (L) thumb for 1st day. Ongoing pain (L) deltoid persisting 9/9/11. No numbness, weakness, or swelling by 7/28/11.
Age: 16.0
Sex: M
Vaccine: FLU3
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: 16 yo male received FLULAVAL 0.5ml IM to LD.
Age: 84.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Hyperhidrosis, Injection site haematoma, Injection site pain, Injection site reaction
Clinical narrative: 24 hrs after receiving ZOSTAVAX vaccine pt. started having pain at injection site, diarrhea, and profuse sweating. Pt. went to ER and was given Hydrocodone/APAP. On approximately 8/31/11 pt. states bruising occurred on Rt. upper arm and swelling on deltoid the size of golf balls.
Age: 84.0
Sex: F
Vaccine: VARZOS
Symptoms: Muscle swelling
Clinical narrative: 24 hrs after receiving ZOSTAVAX vaccine pt. started having pain at injection site, diarrhea, and profuse sweating. Pt. went to ER and was given Hydrocodone/APAP. On approximately 8/31/11 pt. states bruising occurred on Rt. upper arm and swelling on deltoid the size of golf balls.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Swelling, redness of whole upper left arm down to elbow, very sore & warm.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Local reaction
Clinical narrative: Local reaction to right arm.
Age: 1.03
Sex: F
Vaccine: HEPA, HIBV, MMR, VARCEL
Symptoms: Cough, Measles, Pallor, Rash, Rash morbilliform
Clinical narrative: Chart entry dated 8/31/2011: Patient received MMR on 8/18/2011 - was doing well until several days ago, developed cough, coryza, no conjunctivitis, last night developed a diffuse rash - non itchy, non febrile. Has been taking PO and activity levels good. Skin is morbilliform rash blanching over face and trunk and extremities. Assessment: measles uncomplicated clearly exanthem - wild type V exuberant immune response.
Age: 1.03
Sex: F
Vaccine: HEPA, HIBV, MMR, VARCEL
Symptoms: Rhinitis
Clinical narrative: Chart entry dated 8/31/2011: Patient received MMR on 8/18/2011 - was doing well until several days ago, developed cough, coryza, no conjunctivitis, last night developed a diffuse rash - non itchy, non febrile. Has been taking PO and activity levels good. Skin is morbilliform rash blanching over face and trunk and extremities. Assessment: measles uncomplicated clearly exanthem - wild type V exuberant immune response.
Age: 1.07
Sex: F
Vaccine: DTAP, HEPA, MMR, VARCEL
Symptoms: Ataxia, Fall, Feeling drunk
Clinical narrative: Ataxia - onset 9/3/2011, lasted 3-4 days then resolved. No treatment frequent falls, seemed "drunk", walked in circles. MMR & varicella given 9 day prior to onset.
Age: 3.0
Sex: M
Vaccine: DTAP
Symptoms: Injection site discomfort, Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: (L) thigh swollen, red, warm to touch and painful, discomfort - unable to sleep last night R/T pain. Tx - symptomatic compress, TYLENOL or MOTRIN.
Age: 3.0
Sex: M
Vaccine: DTAP
Symptoms: Insomnia
Clinical narrative: (L) thigh swollen, red, warm to touch and painful, discomfort - unable to sleep last night R/T pain. Tx - symptomatic compress, TYLENOL or MOTRIN.
Age: 0.27
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC13
Symptoms: Injection site erythema, Injection site swelling, Screaming
Clinical narrative: This case is 1 of a cluster of 2 patients who experienced similar adverse events following vaccination with DAPTACEL. The event for the second patient was captured in case number 2011-00817. Initial report received from a health care professional on 23 February 2011. A 3-month-old female patient received on 07 January 2011 a left thigh injection (route not reported) of DAPTACEL, sanofi pasteur lot number C3577AA. On 07 January 2011, the patient developed inconsolable high pitched screaming for 8-9 hours after the vaccine with swelling and redness on the left thigh. The outcome was reported as recovered. Follow-up information was received from the health care professional on 05 April 2011. The patient was 9 pounds, 9 ounces at birth, and had 2 sisters. No additional new information was reported. Documents held by sender: None.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV, MMRV
Symptoms: Injection site swelling, Injection site vesicles
Clinical narrative: Initial report received from a health care professional on 07 April 2011. A 5-year-old patient received the following vaccinations on 05 April 2011: an intramuscular left thigh injection (dose 5) of DAPTACEL, lot number C3718AA, an intramuscular left thigh injection of IPOL (dose 4), sanofi pasteur SA lot number E0330, an intramuscular right thigh injection (dose 2) of VAQTA, Merck lot number 0039AA, and a subcutaneous thigh injection (dose 2)of PROQUAD, Merck lot number 1440Z. The patient had no medical history, no known allergies and no concomitant medications. The patient had no illness at the time of vaccination and no other vaccinations within 4 weeks of the recent vaccines. The patient had no adverse events following prior vaccination. On 06 April 2011, the patient developed within 24 hours, left thigh swelling twice the normal size. The mother removed the band aid and noticed a blister, the size of a nickel, at the site of immunization on the left thigh with clear white liquid. The patient was seen by a doctor. The outcome was reported as not recovered. Follow-up information was received 22 June 2011 from a health care professional. PROQUAD had been administered subcutaneously in the patient's right thigh. On 07 April 2011, the patient was seen by their physician and was released. It was not reported if the patient had received any corrective treatments. According to the reporter, the blister had been looking better the next few days after vaccination. An updated recovery status was not provided at the time of the report. Documents held by sender: None.
Age: 4.0
Sex: F
Vaccine: DTAP, FLU3, IPV, MMR
Symptoms: Gait disturbance, Injection site swelling, Injection site warmth
Clinical narrative: Initial report was received on 07 and 16 February 2011 from a health care professional. This case is one of a cluster of two identified patients who experienced similar adverse events following administration of DAPTACEL. The events for the other patient were captured in case 2011-00549. A four year-old patient with no reported past medical history and no illness at the time of vaccination had received a fourth dose right thigh injection of DAPTACEL, lot number C3515AA (route of administration not reported), a fourth dose left thigh injection of IPOL (lot number and route of administration not reported), a second dose left thigh injection of MMR II (Merck lot number and route of injection not reported) and a right thigh injection of FLUVIRIN (Novartis lot number and route of administration not reported) on 02 February 2011 and an unspecified amount of time later, experienced swelling and warmth of right thigh and was also limping. The patient was evaluated by a physician. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was unknown. Follow-up information was received from the health care professional on 12 April 2011. The reaction was on the right thigh and was swollen and warm. The patient was also noted to be limping. The events recovered on an unspecified date. Follow-up information was received 29 April 2011 from a health care professional. The lot number for IPOL was E0204. No additional information was provided at the time of the report. Documents held by sender: none
Age: 0.17
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC, RV5
Symptoms: Screaming
Clinical narrative: This case is 1 of a cluster of 2 patients who experienced similar adverse events following vaccination with DAPTACEL. The event for the second patient was captured in case number 2011-00816. Initial report received from a health care professional on 23 February 2011. A 2-month-old male infant received on 29 December 2010 an injection (route and site not reported) of DAPTACEL, sanofi pasteur lot number C3577AA. On 29 December 2010, the patient developed inconsolable screaming for 3 hours after the vaccine. The outcome was reported as recovered. Follow-up information was received from the health care professional on 05 April 2011. In additional to DAPTACEL, the patient also received his first dose of the following vaccines on 29 December 2010: ACTHIB (sanofi pasteur inc lot number UH253AB, sanofi pasteur SA lot number E0990-1); IPOL (lot number E0123-1); PREVENAR (other manufacturer, lot number 915066); and ROTATEQ (other manufacturer, lot number 12667). The reporter of this case was the same as case 2011-00816. Documents held by sender: None.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site vesicles, Injection site warmth
Clinical narrative: This case is part of a cluster of three children who received DAPTACEL (lot number C3718AA) and each developed vaccination site and/or localized reactions. Initial report received on 27 April 2011 from a health professional. A 5 year old female patient, with no known allergies and no concomitant medications, received a fifth left deltoid intramuscular injection of DAPTACEL (lot number C3718AA) and a fourth right deltoid intramuscular injection of IPOL (lot number G1068-1) on 19 April 2011. The patient had no illness at the time of vaccination. On 20 April 2011, the patient had swelling, redness, heat, itching and blisters on the left arm. By 23 April 2011, the blisters were gone and the other symptoms remained with swelling to the elbow. The patient's recovery status was unknown. Follow-up information was received from a health care professional on 27 May 2011. The patient's outcome was reported as recovered (date not reported). The events for the other two children are captured in cases 2011-02508 and 2011-02510. Documents held by sender: none.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMRV, DTAP, IPV, MMRV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site vesicles
Clinical narrative: Initial report received from a health care professional on 06 May 2011. A 5-year-old male patient, with a history of asthma, received on 03 May 2011 a right thigh intramuscular injection (dose 5) of DAPTACEL, sanofi pasteur lot number C3358AA, a left thigh intramuscular injection of IPOL, sanofi pasteur invalid lot number D0674, and a left thigh subcutaneous injection of PROQUAD, Merck lot number 02837. He had no illness at the time of vaccination, no other vaccines within 4 weeks and took no medications. The patient did not have any adverse event following prior vaccinations. On 04 May 2011, the patient developed an 8 x 5.5 centimeter (cm) red, blistered area on the left thigh. He was seen in the office on 04 May 2011. Later that evening and into the next day, the patient developed red, swollen, painful area on the right thigh where the DAPTACEL was given. The patient was treated with steroids. The outcome was reported as not recovered. Follow-up information was received on 09 June 2011 from a health care professional. The lot number for IPOL was reported as D0674-1, which is a valid sanofi pasteur lot number. No information regarding the patient's recovery status was provided. Documents held by sender: None.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMRV, DTAP, IPV, MMRV
Symptoms: Beta globulin, Blister, Body temperature increased, Erythema, Induration
Clinical narrative: Initial report received from a health care professional on 06 May 2011. A 5-year-old male patient, with a history of asthma, received on 03 May 2011 a right thigh intramuscular injection (dose 5) of DAPTACEL, sanofi pasteur lot number C3358AA, a left thigh intramuscular injection of IPOL, sanofi pasteur invalid lot number D0674, and a left thigh subcutaneous injection of PROQUAD, Merck lot number 02837. He had no illness at the time of vaccination, no other vaccines within 4 weeks and took no medications. The patient did not have any adverse event following prior vaccinations. On 04 May 2011, the patient developed an 8 x 5.5 centimeter (cm) red, blistered area on the left thigh. He was seen in the office on 04 May 2011. Later that evening and into the next day, the patient developed red, swollen, painful area on the right thigh where the DAPTACEL was given. The patient was treated with steroids. The outcome was reported as not recovered. Follow-up information was received on 09 June 2011 from a health care professional. The lot number for IPOL was reported as D0674-1, which is a valid sanofi pasteur lot number. No information regarding the patient's recovery status was provided. Documents held by sender: None.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMRV, DTAP, IPV, MMRV
Symptoms: Injection site pain, Injection site reaction, Injection site scab, Injection site vesicles, Polymerase chain reaction
Clinical narrative: Initial report received from a health care professional on 06 May 2011. A 5-year-old male patient, with a history of asthma, received on 03 May 2011 a right thigh intramuscular injection (dose 5) of DAPTACEL, sanofi pasteur lot number C3358AA, a left thigh intramuscular injection of IPOL, sanofi pasteur invalid lot number D0674, and a left thigh subcutaneous injection of PROQUAD, Merck lot number 02837. He had no illness at the time of vaccination, no other vaccines within 4 weeks and took no medications. The patient did not have any adverse event following prior vaccinations. On 04 May 2011, the patient developed an 8 x 5.5 centimeter (cm) red, blistered area on the left thigh. He was seen in the office on 04 May 2011. Later that evening and into the next day, the patient developed red, swollen, painful area on the right thigh where the DAPTACEL was given. The patient was treated with steroids. The outcome was reported as not recovered. Follow-up information was received on 09 June 2011 from a health care professional. The lot number for IPOL was reported as D0674-1, which is a valid sanofi pasteur lot number. No information regarding the patient's recovery status was provided. Documents held by sender: None.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMRV, DTAP, IPV, MMRV
Symptoms: Rash erythematous, Varicella post vaccine
Clinical narrative: Initial report received from a health care professional on 06 May 2011. A 5-year-old male patient, with a history of asthma, received on 03 May 2011 a right thigh intramuscular injection (dose 5) of DAPTACEL, sanofi pasteur lot number C3358AA, a left thigh intramuscular injection of IPOL, sanofi pasteur invalid lot number D0674, and a left thigh subcutaneous injection of PROQUAD, Merck lot number 02837. He had no illness at the time of vaccination, no other vaccines within 4 weeks and took no medications. The patient did not have any adverse event following prior vaccinations. On 04 May 2011, the patient developed an 8 x 5.5 centimeter (cm) red, blistered area on the left thigh. He was seen in the office on 04 May 2011. Later that evening and into the next day, the patient developed red, swollen, painful area on the right thigh where the DAPTACEL was given. The patient was treated with steroids. The outcome was reported as not recovered. Follow-up information was received on 09 June 2011 from a health care professional. The lot number for IPOL was reported as D0674-1, which is a valid sanofi pasteur lot number. No information regarding the patient's recovery status was provided. Documents held by sender: None.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Inappropriate schedule of drug administration, Injection site discolouration, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Initial case received from a nurse practitioner on 29 October 2010. It involves inappropriate schedule of vaccine administration. A 5-year-old female patient received the following vaccines on 18 August 2010: a first right thigh injection of IPOL (lot number D0532); a third left thigh injection of DTaP (manufacturer and lot number not reported); and a first left thigh injection of MMR (manufacturer and lot number not reported). On 19 August 2010, the patient's parents reported that the IPOL injection site was red, swollen, slightly raised, and warm to the touch. On 25 August 2010 the family again called to report that the reaction had increased to a 3.5 inch area which was red, swollen, warm, and purplish in appearance. Per the parent report, the area eventually extended to a 5 x 6 inch area which lasted 5 days. The patient had no known allergies, no medical conditions, and had not experienced any reactions following previous DTaP vaccinations. Follow-up information was received from the health care professional on 18 January 2011. In addition to IPOL, the patient also received DTaP (GlaxoSmithKline, lot number AC14B091AA) and MMR II (Merck, lot number 0253Z) on 18 August 2010. Per the patient's medical record, the patient's mother called the physician on 19 August 2010 to report that the injection site was red and swollen and "the size of a peach". The area was slightly raised, but was not warm to the touch; the patient had no fever, and was acting normally. The mother was advised to give the patient TYLENOL or MOTRIN and to apply cool packs to the site 10-15 minutes at a time every 1 to 1.5 hours. She was instructed to call back if the patient did not improve. The patient received another dose of IPOL on 10 December 2010 with no associated adverse events. Per the reporter, the patient had received IPOL off schedule due to "parent choice".
Age: 1.06
Sex: M
Vaccine: IPV
Symptoms: Erythema, Skin warm
Clinical narrative: Initial report received from the patient's parent on 15 April 2011. A 12-month-old male patient with no concurrent illnesses, or significant medical history had received a first intramuscular thigh (side not reported) injection of IPOL (lot number unknown) on 30 November 2010. That same day, the patient's face turned red and was warm, but the symptoms resolved the next day. No physician evaluation or treatment was required. No relevant diagnostic tests and / or laboratory data were performed. Documents held by sender: None.
Age: 3.0
Sex: M
Vaccine: HEPA, IPV, PNC13, TDAP
Symptoms: Abnormal behaviour, Distractibility, Psychomotor hyperactivity, Wrong drug administered
Clinical narrative: Initial report was received on 06 June 2011 from a consumer, who is also the patient's parent. This case involved the administration of the wrong vaccine. A three year-old male patient had received the vaccines in June 2011: an intramuscular injection of ADACEL, lot number C3486AA (site and exact date of administration not reported), IPOL (lot number, route and site of administration not reported), Hepatitis A (GSK lot number, route and site of administration not reported) and PREVNAR 13 (Pfizer lot number, route and site of administration not reported) and an unspecified amount of time after vaccinations the "child has changed". According to the mother, he is not listening, is more active and is easily distracted. She states the change is significant enough that family have noticed. The patient has not been evaluated by a physician. Treatments were not reported. The patient had no illness at the time of vaccination. Pre-existing conditions, other medications and adverse events following prior vaccinations were reported as none. No further information was available at the time of the report. The patient's outcome was not recovered. Documents held by sender: none.
Age: 0.3
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Developmental delay, Neurological examination abnormal
Clinical narrative: Initial report was received 10 June 2011 from a consumer, who is also the patient's parent. A four-month-old female patient (also reported as two months of age) had received an injection of IPOL, DTaP (manufacturer unknown), Hib (manufacturer unknown), Hepatitis B (other manufacturer), and PREVNAR (manufacturer Wyeth) vaccines. Lot numbers, routes, sites and dates of administration were not reported. At approximately four months of age, the patient had a neurology workup performed and she had not been meeting her milestones. According to the reporter, the patient was older now and doing better. The reporter declined to provide any specific information pertaining to the event, and also declined to provide either personal or physician contact information. Outcome was not reported. Documents held by sender: None.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema
Clinical narrative: This case is 1 of a cluster of 3 patients who experienced similar adverse events following vaccination with DAPTACEL. The event for the first patient was captured in case number 2010-04790 and the second patient was captured in case number 2010-04791. A 5-year-old child (sex not reported) received on 31 August 2010 an injection (route and site not reported) of DAPTACEL, lot number C3473AA. On the 01 September 2010, the patient developed redness from the shoulder to the elbow on the arm that the injection was given. The outcome was not reported. Follow-up information was received on 25 October 2010 from a health care professional. The patient was reported to be male and had no illness at the time of vaccination. His past medical history was reported as "none". He had received a fifth dose intramuscular right deltoid injection of DAPTACEL and a fourth dose intramuscular left deltoid injection of IPOL, lot number LED204 on 31 August 2010. No further information was provided at the time of the report. The patient's outcome was reported as recovered. Documents held by sender: None.
Sex: U
Vaccine: DTAP, HIBV, IPV
Symptoms: Adverse event, Crying
Clinical narrative: Initial report received from a health care professional on 03 November 2010. A patient (age not provided) received an injection (route, site and date not provided) of DTaP, manufacturer and lot number not provided. The patient had an adverse event. No other information provided. The outcome was not reported. Follow-up information was received from a physician on 07 February 2011. The patient received first doses of the following vaccines on 11 June 2010: DAPTACEL (lot number C3381AA), IPOL (lot number E0123) and ACTHIB (sanofi pasteur SA lot number E0270, sanofi pasteur inc lot number UH083A). The patient was not ill at the time of vaccination. According to mother report, the patient experienced 4 hours of uncontrollable/inconsolable crying after vaccination. Per the reporter, the patient was not brought into the office for examination. The event subsequently resolved at an unspecified time. Documents held by sender: None.
Age: 3.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: This case is part of a cluster of three children who received DAPTACEL (lot number C3718AA) and each developed vaccination site and/or localized reactions. Initial report received on 27 April 2011 from a health professional. A 3 year old female patient, with no known allergies and no concomitant medications, received a fourth intramuscular dose of DAPTACEL (lot number C3718AA) and a third intramuscular injection of IPOL (lot number E0330-1) on 18 April 2011. The site of administration of each vaccine was unknown by the caller. The patient had no illness at the time of vaccination. On 19 April 2011, the patient had swelling and redness of the arm that the DAPTACEL was given in. The patient's recovery status was unknown. Follow-up information was received from a health care professional on 27 May 2011. The patient's outcome was reported as recovered (date not reported). The events for the other two children are captured in cases 2011-02509 and 2011-02510. Documents held by sender: none.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth, Irritability
Clinical narrative: Initial report was received on 07 and 16 February 2011 from a health care professional. This case is one of a cluster of two identified patients who experienced similar adverse events following administration of DAPTACEL. The events for the other patient were captured in case 2011-00550. A four year-old patient with no reported past medical history and no illness at the time of vaccination had received a fourth dose right arm injection of DAPTACEL, lot number C3515AA (route of administration not reported) and a fourth dose right arm injection of IPOL (lot number and route of administration not reported) on 04 February 2011 and an unspecified amount of time later, experienced swelling, redness, warmth and itching of the entire arm (also reported as the upper arm toward the elbow). The patient was also reported to have "whined all night". The patient was evaluated by a physician. Treatments were not reported. No further information was available at the time of the report. The patient's outcome was unknown. Follow-up information was received from the health care professional on 12 April 2011. The patient had not received any other vaccines within 4 weeks of 04 February 2011, was not taking any concomitant medications, and was not ill at the time of vaccination. The outcome was reported as recovered. No additional information was provided. Follow-up information was received 29 April 2011 from a health care professional. IPOL, lot number E0204, had been administered in the right deltoid. No additional information was provided. Documents held by sender: none.
Age: 52.0
Sex: F
Vaccine: FLUX
Symptoms: Erythema, Pain in extremity, Pruritus, Skin burning sensation, Skin warm
Clinical narrative: ARM TURNED REAL RED LIKE A BIG HIVE 6 INCHES LONG AND 2 TO 3 INCHES WIDE IT ITCHES, BURNS, FEELS HOT TO TOUCH AND PAIN, THIS HAS HAPPENED FOR THE LAST THREE YEARS AND SEEMS TO BE GETTING WORSE.
Age: 1.58
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site urticaria, Urticaria
Clinical narrative: Hives on chin, then one on opposite side of face, then upper legs, then stomach
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site warmth
Clinical narrative: sore and hot red lump about 3 inches long at injection site
Age: 34.0
Sex: M
Vaccine: FLU3
Symptoms: Influenza, Nasopharyngitis, Pyrexia, Rhinorrhoea
Clinical narrative: cold / flu symptoms, runny nose, fever
Age: 19.0
Sex: M
Vaccine: HPVX
Symptoms: Urticaria
Clinical narrative: Urticaria (hives) covering abdomen, arms, legs, face
Age: 32.0
Sex: M
Vaccine: MMR
Symptoms: Hypersensitivity, Pruritus, Urticaria
Clinical narrative: Hives/intense itching/allergic reaction
Age: 43.0
Sex: M
Vaccine: FLUN3
Symptoms: Hyperhidrosis, Tremor
Clinical narrative: Five hours following vaccine administration patient became diaphoretic and had uncontrollable trembling. EMS was called after patient was examined by providers at clinic and transported to hospital.
Age: 21.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site pain, Muscular weakness, Pain in extremity, Swelling
Clinical narrative: sore and weak arm, pain at injection site, mild swelling,
Age: 16.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: HLA marker study, Narcolepsy, Sleep study
Clinical narrative: Narcolepsy
Age: 57.0
Sex: M
Vaccine: FLU3
Symptoms: Epicondylitis, Myalgia, Pain, Pain in extremity, Tendon pain
Clinical narrative: Pain in the right outer arm, not joint. Painful to open objects, make a fist, lift small items. No change as of 9/10/11. Pain (7 of 10) appears to be muscle related or tendons. A doctor diagnosed recently as tennis elbow, despite no exertion to cause it.
Age: 10.0
Sex: M
Vaccine: TDAP
Symptoms: Cough, Cyanosis, Decreased appetite, Oropharyngeal pain, Thirst decreased
Clinical narrative: 9/10/2011 HE GOT WORST SO I BROUGHT HIM TO SEE THE DOCTOR. HE IS NOT EATING OR DRINKING.
Age: 16.0
Sex: F
Vaccine: TDAP
Symptoms: Blindness, Syncope, Visual impairment
Clinical narrative: Patient received ADACEL vaccine and shortly after she got spots in her vision then lost vision completely. She then fainted. Her father called 911 and paramedics took over care of patient when they arrived.
Age: 68.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Complained of redness & swelling in bicep of right arm (injection site of PNEUMOVAX 23). Follow up: spoke with pt via phone 9/10/11 11:39am CDT reaction resolving nicely.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Local swelling, Myalgia, Skin warm
Clinical narrative: Pt reports 36 hrs after injection administered - localized swelling, warmth, redness & muscle pain - no treatment at this time.
Age: 23.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Rash, Tachycardia
Clinical narrative: Dizzy spells, tachycardia, rash in the forearms.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site necrosis, Injection site pain, Wound
Clinical narrative: Approximately 2 weeks after receiving the shot, the patient started experiencing a "sharp, constant pain" in the area of administration, followed by mild necrosis of the superficial epidermis layer of the skin in the area surrounding the initial injection. The diameter of the wound is approximately 1.5 cm and it does not appear to be infected - the pt is using NEOSPORIN.
Age: 55.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Atrophy, Erythema, Oedema peripheral, Rash, Skin warm
Clinical narrative: Pt called me 9/9 & told me arm was swollen, warm to the touch & had an indentation with a red line. I advised having adverse Rxn, pt went to ER. - around 8pm. ER said rxn to vaccine. Gave BENADRYL shot. Arm today (9/10) still swollen; has rash; not as warm but red indentation moved down arm. Pt put on steroids.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Retching
Clinical narrative: High fever, couldn't get of bed, retching. Symptoms resolved within day of two.
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Computerised tomogram abnormal, Computerised tomogram head, Concussion, Loss of consciousness, Subdural haematoma
Clinical narrative: Passed out - Hit head-2 places, sub dura bleed-Traumatic Brain Injury, Seizures
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Syncope, Traumatic brain injury
Clinical narrative: Passed out - Hit head-2 places, sub dura bleed-Traumatic Brain Injury, Seizures
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Blood test, Computerised tomogram, Convulsion, Craniocerebral injury, Electrocardiogram
Clinical narrative: Passed out - Hit head-2 places, sub dura bleed-Traumatic Brain Injury, Seizures
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, MNQ, TDAP
Symptoms: Electroencephalogram, Head injury, Loss of consciousness, Nuclear magnetic resonance imaging, Subdural haemorrhage
Clinical narrative: Passed out - Hit head-2 places, sub dura bleed-Traumatic Brain Injury, Seizures
Age: 30.0
Sex: F
Vaccine: FLUX
Symptoms: Borrelia test, Full blood count, Immunology test, Joint swelling, Metabolic function test normal
Clinical narrative: Joint swelling - started in both knees, left more than right. Then progressed to wrist/elbow/ankle swelling and hives to arms and legs only. Called doctor, told to take Benadryl and Pepcid, continued to get worse without relief. Went to ER and received steroids, Benadryl, and Pepcid. Continue to have symptoms, but now improved.
Age: 30.0
Sex: F
Vaccine: FLUX
Symptoms: Urticaria, White blood cell count increased
Clinical narrative: Joint swelling - started in both knees, left more than right. Then progressed to wrist/elbow/ankle swelling and hives to arms and legs only. Called doctor, told to take Benadryl and Pepcid, continued to get worse without relief. Went to ER and received steroids, Benadryl, and Pepcid. Continue to have symptoms, but now improved.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Patient has swelling and tenderness accompanied with pain on the injection site on the left deltoid.
Age: 78.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Dyskinesia, Headache, Movement disorder, Pyrexia
Clinical narrative: One and a half hours of severe shaking, violent whole body involved jerking, like a seizure that wouldn't quit, followed by regular chills, fever, headache.
Age: 78.0
Sex: F
Vaccine: FLUX
Symptoms: Tremor
Clinical narrative: One and a half hours of severe shaking, violent whole body involved jerking, like a seizure that wouldn't quit, followed by regular chills, fever, headache.
Age: 52.0
Sex: M
Vaccine: FLU3
Symptoms: Burning sensation, Paraesthesia, Pharyngeal oedema, Rash, Rash pruritic
Clinical narrative: Hive-like rash on neck and chest. Rash was itchy, burning, and tingling. Also throat fullness, No chest pain or SOA. Took Benadryl at 3:15am with improvement in symptoms. Symptoms returned between 8:30-9:00am on 9/11/2011. Went to ER. Was told rash was likely a reaction to flu shot. Given Prednisone x 10 days and Benadryl.
Age: 52.0
Sex: M
Vaccine: FLU3
Symptoms: Vaccination complication
Clinical narrative: Hive-like rash on neck and chest. Rash was itchy, burning, and tingling. Also throat fullness, No chest pain or SOA. Took Benadryl at 3:15am with improvement in symptoms. Symptoms returned between 8:30-9:00am on 9/11/2011. Went to ER. Was told rash was likely a reaction to flu shot. Given Prednisone x 10 days and Benadryl.
Age: 1.69
Sex: M
Vaccine: VARCEL, MMR, VARCEL, MMR
Symptoms: Eyelid oedema, Lip swelling, Oedema peripheral, Rash generalised, Swelling face
Clinical narrative: Swollen face, arms, legs within hours of vaccination. Next morning eyes swelled shut, swollen tongue and lips, caused trip to ER. Instructed to give Benadryl & not have booster. Child vomiting by that evening. 48 hrs later, rash all over body (not pox). Never had reaction from other routine vacs other than cranky.
Age: 1.69
Sex: M
Vaccine: VARCEL, MMR, VARCEL, MMR
Symptoms: Swollen tongue, Vomiting
Clinical narrative: Swollen face, arms, legs within hours of vaccination. Next morning eyes swelled shut, swollen tongue and lips, caused trip to ER. Instructed to give Benadryl & not have booster. Child vomiting by that evening. 48 hrs later, rash all over body (not pox). Never had reaction from other routine vacs other than cranky.
Age: 1.69
Sex: M
Vaccine: VARCEL, MMR, VARCEL, MMR
Symptoms: Culture throat, Urticaria
Clinical narrative: Swollen face, arms, legs within hours of vaccination. Next morning eyes swelled shut, swollen tongue and lips, caused trip to ER. Instructed to give Benadryl & not have booster. Child vomiting by that evening. 48 hrs later, rash all over body (not pox). Never had reaction from other routine vacs other than cranky.